Search results for: Antibiotics
Filter search results
OHE at ISPOR Europe 2023
13 November 2023, 12:00am
…Poster Session Time: 10:30 – 13:30 Discussion Period: 12:30 – 13:30 Poster Session Is Stedi Steady? an Exploration of the Uncertainties Underlying the Quantification of the Broader Value of Antibiotics…
Cost and Benefits of Pharmaceutical Research
1 May 1987
…medical research in this context means pharmaceutical research. Almost all the medical progress since 1948 has been made possible by advances in pharmacology – antibiotics, anaesthetics, muscle relaxants, and immuno-suppressant…
The Dynamics of Drug Shortages
9 January 2024
…Oncology, 24, pp.v17–v22. 10.1093/annonc/mdt324. Eversana, 2022. English Pharmacies Making a Loss When Dispensing Strep A Antibiotics, Amid Surge in Infections. Navlin Daily. Available at: https://www.navlindaily.com/article/15115/english-pharmacies-making-a-loss-when-dispensing-strep-a-antibiotics-amid-surge-in-infections [Accessed 7 Jun. 2023]. Francois, C., Gawlik,…
OHE at HTAi Rome
12 July 2017
…drugs is a wide-spreading medical threat. OHE has also recently published a related Briefing, entitled: Assessing the Value of New Antibiotics: Additional Elements of Value for Health Technology Assessment Decisions….
Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?
1 October 2017
…On the one hand, bad practice favours the spread of infections, such as overuse of antibiotics in human and veterinary care, and poor prevention and hygiene practices. On the other…
Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines
5 June 2025
…ADRs and treatment ineffectiveness, PGx testing can be used to inform prescribing decisions. PGx testing guidelines exist for many commonly prescribed medicines, including blood thinners, antibiotics, and anti-cancer agents. Internationally…
OHE’s submission for the DHSC’s next 10 years of planning
9 December 2024
…implications. The UK is a world leader in novel incentive models of payment – NICE and NHS England’s pioneering trial of the ‘subscription’ model for antibiotics, has the potential to…
Taking STRIDES: The value of diagnostics against AMR
10 June 2025
…and projecting public health: Spectrum value: Enables use of narrow-spectrum antibiotics by identifying specific pathogens and resistance patterns. Transmission value: Reduces the spread of infectious and resistant pathogens through earlier detection and…
Reflections from Adrian Towse on decades of HEOR research and impact
11 November 2025
…from new drugs. I began work in this area 15 years ago, identifying the reasons for the market failures leading to the lack of new antibiotics, and modelling the size…